STOCK TITAN

Michael Amoroso (NASDAQ: DTIL) reports sale of 34,799 shares for $145,202

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DTIL reported a Form 144 filing in which Michael Amoroso indicated a sale of 34,799 common shares on 01/22/2026 for $145,202.30. The filing also shows 20,559 common shares vested as restricted stock on 02/17/2026 as compensation.

Positive

  • None.

Negative

  • None.

Insights

Routine insider sale and related restricted stock vesting were disclosed.

The filing lists a proposed or reported sale of 34,799 common shares with proceeds of $145,202.30, and separately records the vesting of 20,559 common shares as restricted stock on 02/17/2026.

These items are administrative disclosures of insider activity and compensation; timing and further trading details are governed by applicable rules and the broker-dealer handling the sale.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the DTIL Form 144 disclose?

The Form 144 disclosed a reported sale of 34,799 common shares and the vesting of 20,559 common shares as restricted stock. The sale is shown with a transaction date of 01/22/2026 and the vesting date is 02/17/2026.

Who filed the Form 144 for DTIL?

The filing lists Michael Amoroso as the reporting person and shows Fidelity Brokerage Services LLC as the broker. The document includes addresses for both the reporting person and the brokerage firm as presented in the excerpt.

How much proceeds were reported for the DTIL sale?

The Form 144 shows proceeds of $145,202.30 associated with the reported sale of 34,799 common shares. That dollar amount appears alongside the sale entry dated 01/22/2026 in the excerpt.

What shares vested as compensation in the DTIL filing?

The excerpt shows 20,559 common shares vested as restricted stock on 02/17/2026 under a compensation entry. The record labels the vesting as restricted stock vesting tied to the issuer.
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

96.05M
22.56M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
DURHAM